KCTD7 anticorps (AA 112-180)

N° du produit ABIN1387694

L’anticorps Lapin Polyclonal anti-KCTD7 a été validé pour WB, ELISA, FACS, ICC, IF (cc), IF (p), IHC (fro) et IHC (p). Il convient pour détecter KCTD7 dans des échantillons de Humain.

Aperçu rapide pour KCTD7 anticorps (AA 112-180) (ABIN1387694)

Antigène: KCTD7 (Potassium Channel Tetramerisation Domain Containing 7 (KCTD7))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp KCTD7 est non-conjugé

Application: Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-KCTD7 anticorps

Épitope: AA 112-180

Réactivité croisée: Humain

Homologie: Mouse,Rat,Dog,Cow,Sheep,Pig,Horse,Chicken,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human KCTD7

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur KCTD7

Antigène: KCTD7 (Potassium Channel Tetramerisation Domain Containing 7 (KCTD7))

Autre désignation: KCTD7

Sujet:

Synonyms: BTB/POZ domain containing protein KCTD7, EPM3, FLJ32069, Potassium channel tetramerisation domain containing 7, KCTD7_HUMAN.

Background: Epilepsy affects about 0.5 % of the world?s population and has a large genetic component. Epilepsy results from an electrical hyperexcitability in the central nervous system. Potassium channels are important regulators of electrical signaling, determining the firing properties and responsiveness of a variety of neurons. Benign familial neonatal convulsions (BFNC), an autosomal dominant epilepsy of infancy, has been shown to be caused by mutations in the KCNQ2 or the KCNQ3 potassium channel genes. KCNQ2 and KCNQ3 are voltage-gated potassium channel proteins with six putative transmembrane domains. Both proteins display a broad distribution within the brain, with expression patterns that largely overlap.

ID gène: 154881

UniProt: Q96MP8